282 related articles for article (PubMed ID: 25915207)
1. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
[TBL] [Abstract][Full Text] [Related]
2. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
Peng F; Zhang H; Du Y; Tan P
Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.
Wang J; Li L; Wu K; Ge W; Zhang Z; Gong L; Yuan D
Pharmazie; 2016 Oct; 71(10):598-602. PubMed ID: 29441929
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
5. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
[TBL] [Abstract][Full Text] [Related]
6. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling.
Huang Z; Huang Y; He H; Ni J
Mol Med Rep; 2015 Sep; 12(3):3916-3922. PubMed ID: 26017117
[TBL] [Abstract][Full Text] [Related]
7. Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through β-catenin signaling.
Zheng L; Li N; Guo F; Jian XC; Jiang CH; Yin P; Min AJ; Huang L
Mol Med Rep; 2015 Mar; 11(3):2255-61. PubMed ID: 25378227
[TBL] [Abstract][Full Text] [Related]
8. BMI1 activates P-glycoprotein via transcription repression of
Chen MK; Zhou JH; Wang P; Ye YL; Liu Y; Zhou JW; Chen ZJ; Yang JK; Liao DY; Liang ZJ; Xie X; Zhou QZ; Xue KY; Guo WB; Xia M; Bao JM; Yang C; Duan HF; Wang HY; Huang ZP; Qin ZK; Liu CD
Aging (Albany NY); 2021 Jul; 13(14):18310-18330. PubMed ID: 34270461
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 transcriptionally regulated carbonic anhydrase 9 mediates the chemoresistance of tongue cancer via maintaining intracellular pH.
Zheng G; Peng C; Jia X; Gu Y; Zhang Z; Deng Y; Wang C; Li N; Yin J; Liu X; Lu M; Tang H; He Z
Mol Cancer; 2015 Apr; 14():84. PubMed ID: 25890268
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells.
Hong Y; Shang C; Xue YX; Liu YH
Med Sci Monit; 2015 Apr; 21():1002-7. PubMed ID: 25858624
[TBL] [Abstract][Full Text] [Related]
11. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
[TBL] [Abstract][Full Text] [Related]
12. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
Wang X; Guo H; Yao B; Helms J
Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma.
Lin CW; Sun MS; Wu HC
Int J Oncol; 2014 Aug; 45(2):710-8. PubMed ID: 24821609
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma.
Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C
Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955
[TBL] [Abstract][Full Text] [Related]
17. Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma.
He Q; Liu Z; Zhao T; Zhao L; Zhou X; Wang A
Int J Biol Sci; 2015; 11(1):1-10. PubMed ID: 25552924
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer.
Li Z; Wang Y; Yuan C; Zhu Y; Qiu J; Zhang W; Qi B; Wu H; Ye J; Jiang H; Yang J; Cheng J
Lab Invest; 2014 Dec; 94(12):1431-45. PubMed ID: 25286028
[TBL] [Abstract][Full Text] [Related]
19. [Silencing of survivin gene enhances chemosensitivity of human tongue cancer cell line Tca8113 to cisplatin].
Xu JH; Pan CB; Huang HZ; Zhang B; Wang JG; Zhang LT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 May; 42(5):280-3. PubMed ID: 17686279
[TBL] [Abstract][Full Text] [Related]
20. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.
Gu Y; Fan S; Xiong Y; Peng B; Zheng G; Yu Y; Ouyang Y; He Z
FEBS Lett; 2011 Mar; 585(6):881-7. PubMed ID: 21334329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
